Earnings · China A-shares
Wuhan Healthgen Biotechnology Corp Class A (688765) earnings
Wuhan Healthgen Biotechnology Corp Class A published its Q3 report on 2026-10-27: net profit +12.68% year on year, -3.70% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +2.60% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- +12.68%
- Excl. one-offs YoY
- -3.70%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -5.41% | — |
| 3 days | +2.60% | — |
| 7 days | +8.86% | — |
| 14 days | +1.35% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 2 of 3 reports (average -1.93%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | -¥105.89M | +12.68% | -3.70% | +41.55% | -0.30 | -3.72% | +2.60% | — | — |
| 2026 interim report | 2026-08-27 | -¥62.76M | +23.12% | +2.18% | +43.77% | -0.18 | -2.19% | +0.49% | -8.70% | +0.24% |
| 2026 Q1 report | 2026-04-28 | -¥36.05M | +25.21% | +16.49% | +132.39% | -0.10 | -1.25% | -8.88% | -25.55% | -24.92% |
| 2025 annual report | 2026-04-28 | -¥157.04M | -3.75% | -5.32% | +89.80% | -0.56 | -16.92% | -8.88% | -25.55% | -24.92% |
| 2025 Q3 report | 2025-10-24 | -¥121.27M | -8.44% | -7.89% | -8.51% | -0.45 | -22.43% | — | — | — |
| 2024 Q3 report | 2025-10-24 | -¥111.83M | — | — | — | -0.42 | -16.55% | — | — | — |
| 2025 interim report | 2025-09-23 | -¥81.63M | -3.86% | -3.04% | +33.32% | -0.30 | -14.56% | — | — | — |
| 2025 Q1 report | 2025-06-24 | -¥48.20M | -64.38% | -22.81% | -37.89% | -0.18 | -8.35% | — | — | — |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.